🚀 We are very happy with the progress our PMed4HB project team, funded by the Asociación Española Contra el Cáncer, is achieving.

🎯 This project, initiated in December 2022, aims to advance precision medicine for hepatoblastoma by identifying new therapies and predictive biomarkers using a unique European biorepository. 🧬

👩🏻‍💻 During yesterday's regular meeting, Laura Zanatto from Pau Sancho-Bru's laboratory (Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)) updated us on the progress in establishing and characterizing a platform of patient-derived organoids (PDOs) and how they are being used to propose new therapeutic strategies.